Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)

Objective Focal endoscopic resection (ER) followed by radiofrequency ablation (RFA) safely and effectively eradicates Barrett's oesophagus (BO) containing high-grade dysplasia (HGD) and/or early cancer (EC) in smaller studies with limited follow-up. Herein, we report long-term outcomes of combined ER and RFA for BO (HGD and/or EC) from a single-arm multicentre interventional study. Design In 13 European centres, patients with BO≤12 cm with HGD and/or EC on 2 separate endoscopies were eligible for inclusion. Visible lesions (<2 cm length; <50% circumference) were removed with ER, followed by serial RFA every 3 months (max 5 sessions). Follow-up endoscopy was scheduled at 6 months after the first negative post-treatment endoscopic control and annually thereafter. Outcomes: complete eradication of neoplasia (CE-neo) and intestinal metaplasia (CE-IM); durability of CE-neo and CE-IM (once achieved) during follow-up. Biopsy and resection specimens underwent centralised pathology review. Results 132 patients with median BO length C3M6 were included. After entry-ER in 119 patients (90%) and a median of 3 RFA (IQR 3–4) treatments, CE-neo was achieved in 121/132 (92%) and CE-IM in 115/132 patients (87%), per intention-to-treat analysis. Per-protocol analysis, CE-neo and CE-IM were achieved in 98% and 93%, respectively. After a median of 27 months following the first negative post-treatment endoscopic control, neoplasia and IM recurred in 4% and 8%, respectively. Mild-to-moderate adverse events occurred in 25 patients (19%); all managed conservatively or endoscopically. Conclusions In patients with early Barrett's neoplasia, intensive multimodality endotherapy consisting of ER combined with RFA is safe and highly effective, and the treatment effect appears to be durable during mid-term follow-up. Trial registration number NTR 1211, http://www.trialregister.nl.

[1]  S. Spechler,et al.  The Risk of Lymph-Node Metastases in Patients With High-Grade Dysplasia or Intramucosal Carcinoma in Barrett's Esophagus: A Systematic Review , 2012, The American Journal of Gastroenterology.

[2]  L. Gossner,et al.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.

[3]  N. Soehendra,et al.  Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial , 2011, Gut.

[4]  E. Schoon,et al.  Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. , 2013, Gastroenterology.

[5]  P. Mavrelis,et al.  Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry , 2010, Endoscopy.

[6]  Masoud Panjehpour,et al.  Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.

[7]  F. T. ten Kate,et al.  Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens , 2010, Endoscopy.

[8]  B. Overholt,et al.  Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus. , 2010, Gastrointestinal endoscopy.

[9]  N. Shaheen,et al.  Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. , 2012, Gastrointestinal endoscopy.

[10]  R. Sampliner,et al.  Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[11]  R. Odze,et al.  Buried Metaplasia After Endoscopic Ablation of Barrett's Esophagus: A Systematic Review , 2011, The American Journal of Gastroenterology.

[12]  Hugh Barr,et al.  Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. , 2012, Gastroenterology.

[13]  M. Vieth,et al.  Ablation of residual Barrett’s epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study) , 2013, Endoscopy.

[14]  R. Sampliner,et al.  Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria , 1998, American Journal of Gastroenterology.

[15]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[16]  Michael Vieth,et al.  Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). , 2005, Gastrointestinal endoscopy.

[17]  L. Gossner,et al.  Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach , 2002, European journal of gastroenterology & hepatology.

[18]  Hugh Barr,et al.  Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. , 2013, Gastroenterology.

[19]  A. Bhattacharyya,et al.  Long-term follow-up of intestinal metaplasia of the gastric cardia , 2000, American Journal of Gastroenterology.

[20]  D. Fleischer,et al.  A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). , 2008, Endoscopy.

[21]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[22]  P. Fockens,et al.  Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[23]  P. Fockens,et al.  Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.

[24]  Kenneth J. Chang,et al.  Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial* , 2010, Endoscopy.

[25]  P. Fockens,et al.  Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. , 2005, Endoscopy.

[26]  J. Goldblum,et al.  Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. , 1998, Gastroenterology.

[27]  G. Ginsberg,et al.  Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium. , 2013, Gastroenterology.

[28]  Prateek Sharma,et al.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus. , 2011, Gastroenterology.

[29]  Kenneth J. Chang,et al.  Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. , 2008, Gastrointestinal endoscopy.

[30]  P. Fockens,et al.  Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients , 2008, Endoscopy.

[31]  Hiroshi Mashimo,et al.  Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. , 2011, Gastroenterology.

[32]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[33]  Prateek Sharma,et al.  Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. , 2005, Gastrointestinal endoscopy.

[34]  Paul Fockens,et al.  Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[35]  Kenneth K Wang,et al.  Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  N. Soehendra,et al.  Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients , 2010, Gut.

[37]  R C Heading,et al.  Barrett's oesophagus. , 1987, British medical journal.

[38]  B. Overholt,et al.  Does Ablative Therapy for Barrett Esophagus Affect the Depth of Subsequent Esophageal Biopsy as Compared With Controls? , 2010, Journal of clinical gastroenterology.

[39]  E. Schoon,et al.  Radiofrequency ablation and endoscopic resection in a single session for Barrett’s esophagus containing early neoplasia: a feasibility study , 2012, Endoscopy.

[40]  B. Petersen,et al.  A lexicon for endoscopic adverse events: report of an ASGE workshop. , 2010, Gastrointestinal endoscopy.

[41]  C. Gutschow,et al.  High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. , 2006, Endoscopy.

[42]  M. Vieth,et al.  Properties of the Neosquamous Epithelium After Radiofrequency Ablation of Barrett's Esophagus Containing Neoplasia , 2009, The American Journal of Gastroenterology.